login
login

Europe Daily Bulletin No. 12811

14 October 2021
Contents Publication in full By article 25 / 33
EU RESPONSE TO COVID-19 / Health
CureVac withdraws its first Covid-19 vaccine, Commission ‘examines consequences’ on its contract with company
Ljubljana, 13/10/2021 (Agence Europe)

The European Medicines Agency (EMA) announced, on Tuesday 12 October, that it is ending the rolling review of the Covid-19 CVnCoV vaccine developed by the pharmaceutical company CureVac.

In its letter to EMA , the company stated that it withdrew because it decided to focus its efforts on a different Covid-19 vaccine development programme”, the EMA said, noting that CVnCoV had so far shown only modest efficacy (see EUROPE B12743A13).

The European Commission had concluded an advance...

Contents

SECTORAL POLICIES
EXTERNAL ACTION
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
INSTITUTIONAL
SOCIAL AFFAIRS - EDUCATION
EU RESPONSE TO COVID-19
NEWS BRIEFS